NCT02127164View on ClinicalTrials.gov

Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Gastrointestinal InjuryComplicated Diverticulitis
Interventions
DEVICE

"Veraflo device, Dakin's solution"

Veraflo device will be installed on the wound to create negative pressure after surgery. Dakin's solution will be instilled through this device into the wound at the regular intervals.

Trial Locations (1)

85724

University of Arizona Medical Center, Tucson

All Listed Sponsors
collaborator

3M

INDUSTRY

lead

University of Arizona

OTHER

NCT02127164 - Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries | Biotech Hunter | Biotech Hunter